Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.3B
Avg Funding
$52.8M
Global Reach
8
countries

Top Cities for Therapeutics

Boulder
Milwaukee
San Diego
Cambridge
Dallas
Melbourne

Recently Funded Companies

Export
Boulder, United States

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

$311.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Milwaukee, United States

N-Zyme Biomedical develops pepsin inhibitor therapies and drug formulations for reflux diseases such as LPR and GERD.

$2.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.

$2.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.

$250K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology.

$307K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Melbourne, Australia

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

$4.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.

$250K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Biolevate provides an AI platform for life sciences teams to manage regulated operations through evidence-driven, auditable workflows.

$34.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Mont-saint-guibert, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

$11.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

$11.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

$16.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland

Piomic Medical develops regenerative medical devices using optical and magnetic stimulation to support tissue regeneration.

$25.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

$1.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Frederiksberg, Denmark

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

$93.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

$92.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Minneapolis, United States

Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.

$5.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

$123.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

$10.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Emeryville, United States

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

$44.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Vienna, Austria

Aitiologic is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy.

$7.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

New York, United States

ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.

$37.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

$400.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

$2.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Framingham, United States

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

$78.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Paris, France

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

$3.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$52.8M
Total Funding Tracked
$1.3B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Diego
2 companies$3.2M
2.Paris
2 companies$38.3M
3.San Francisco
2 companies$95.0M
4.Boulder
1 companies$311.0M
5.Milwaukee
1 companies$2.8M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,733 Therapeutics Startups (2026) — Recently Funded — Page 3 | VCBacked